Randomization Unethical For VNS Depression Patients, Cyberonics Says
Cyberonics says a one-year, 300-patient, non-randomized study should be sufficient to remove placebo effects encountered in its clinical trial evaluating VNS Therapy for depression
Cyberonics says a one-year, 300-patient, non-randomized study should be sufficient to remove placebo effects encountered in its clinical trial evaluating VNS Therapy for depression